International Study to Evaluate Two Programs of Support for Patients With Advanced Cancer and Their Families
DIAdIC
International Randomized Controlled Trial to Evaluate the Effectiveness of a Nurse-delivered (FOCUS+) and a Web-based (iFOCUS) Psychoeducational Intervention for People With Advanced Cancer and Their Family Caregivers
1 other identifier
interventional
431
6 countries
13
Brief Summary
The overall aim of this project is to evaluate the effectiveness, cost-effectiveness and mechanisms of action of two psychoeducational interventions (a face-to-face nurse-led intervention called FOCUS+ and an eHealth intervention called iFOCUS) aimed at improving the emotional function and self-efficacy of patients with advanced cancer and their family caregiver. Both interventions are compared to care as usual. Both interventions focus on teaching dyads optimal ways to jointly manage the implications of advanced cancer and responding to their priority concerns and are designed to be tailored to the specific needs and wishes of the patient-caregiver dyads. Tailoring is based on information about the dyad obtained at enrollment (e.g. age, relationship, etc.) and the responses in the intervention sessions. The overarching aim is addressed by five core intervention components:
- Effect on the emotional function and self-efficacy (primary outcomes), appraisal of illness, uncertainty, hopelessness, coping, dyad communication, quality of life and healthcare resource use of patients with advanced cancer and their family caregivers
- Cost-effectiveness
- Effects on vulnerable subgroups (particularly women and those of lower socioeconomic status)
- Effectiveness in different healthcare systems
- To evaluate the implementation process of the interventions in terms of the acceptability, feasibility, usefulness as perceived by patients, family caregivers and healthcare staff in each country, and their mechanisms of action.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2021
Typical duration for not_applicable
13 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 27, 2020
CompletedFirst Posted
Study publicly available on registry
November 12, 2020
CompletedStudy Start
First participant enrolled
February 24, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2023
CompletedJune 12, 2024
June 1, 2024
2.6 years
October 27, 2020
June 10, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in emotional functioning
For patients and for caregivers: EORTC 10 emotional function items
T1 (baseline + 12 weeks)
Change in self-efficacy
For patients and for caregivers: the Lewis´ Cancer self-efficacy scale
T1 (baseline + 12 weeks)
Secondary Outcomes (13)
Change in emotional functioning
T2 (baseline + 24 weeks)
Change in self-efficacy
T2 (baseline + 24 weeks)
Change in patient quality of life
T1 (baseline + 12 weeks), T2 (baseline + 24 weeks)
Change in caregiver quality of life
T1 (baseline + 12 weeks), T2 (baseline + 24 weeks)
Change in patient social well-being
T1 (baseline + 12 weeks), T2 (baseline + 24 weeks)
- +8 more secondary outcomes
Study Arms (3)
FOCUS+
EXPERIMENTALDyads in the FOCUS+ arm will receive the face-to-face nurse-led FOCUS+ program.
iFOCUS
EXPERIMENTALDyads in the iFOCUS arm will receive the web-based iFOCUS program.
Standard care
NO INTERVENTIONDyads in the control group will receive standard care as usual, as determined by the healthcare system in the participating countries. The dose and frequency of usual care will be as deemed appropriate by the medical practitioner in charge of their treatment.
Interventions
Home-based psycho-educational intervention consisting of two 90-minute home visits and one 30-minute video-conferencing session, conducted by a trained intervention nurse over a period of 12 weeks (4 weeks between each session). The intervention is comprehensively manualized and there is a protocol to guide delivery of the intervention for each home visit and video call. The content of the sessions is always tailored to the needs of the dyads, so certain topics can be discussed more in-depth and specific information can be shared. The nurses who will deliver the FOCUS+ intervention will receive an extensive online training and additional continuous follow-up training to provide them with the knowledge and skills required to successfully implement the intervention. A FOCUS+ core booklet is provided as a supporting guide for the dyads that they can refer to at their own discretion and reinforces key intervention messages linked to the core components of the intervention.
Self-managed psycho-educational intervention that is completed autonomously by the patient-caregiver dyads together. It encompasses four sessions (with three weeks between each session) over a period of 12 weeks. The sessions are completed simultaneously by the patient and the family caregiver, sitting side by side at a computer. Patient-caregiver dyads have flexibility as to when they want to complete the intervention session. Based on the information patients and caregivers provided at enrollment and during the web-based sessions, they receive tailored individual and dyadic messages. An online personal workbook is provided containing the results of the interactive exercises that are provided to the dyads during the web-sessions. Any information brochures, leaflets and information sheets that the dyad indicated as 'of interest to them' during the web-sessions will be included as a hyperlink in their personal workbook.
Eligibility Criteria
You may qualify if:
- Diagnosis of cancer: solid organ (lung, colorectal, breast, prostate and other)
- No longer receives curative treatment (only life-prolonging or palliative treatments)
- Written informed consent
- Lives within feasible distance for intervention nurses to travel
You may not qualify if:
- Brain cancer, non-solid cancers
- Prognosis of less than 3 months
- Has no informal caregivers
- \< 18 years old
- Unable to participate in available languages
- FAMILY CAREGIVER
- Written informed consent
- Primary informal caregiver as determined by the patient
- Lives within feasible distance for intervention nurses to travel
- Unable to physically or mentally participate
- Cancer diagnosis in the last 12 months
- \<18 years old
- Unable to participate in available languages
- DYAD
- Patient and/or family caregivers has access to and is familiar with use of internet
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Vrije Universiteit Brussellead
- Erasmus Medical Centercollaborator
- King's College Londoncollaborator
- Queen's University, Belfastcollaborator
- University Ghentcollaborator
- University of Copenhagencollaborator
- University of Dublin, Trinity Collegecollaborator
- University College Dublincollaborator
- Azienda USL di Reggio Emiliacollaborator
- European Commissioncollaborator
Study Sites (13)
AZ Maria Middelares
Ghent, Belgium
AZ Sint-Lucas
Ghent, Belgium
Universitair Ziekenhuis Gent
Ghent, Belgium
AZ Damiaan
Ostend, Belgium
Herlev University Hospital
Copenhagen, Denmark
Rigshospitalet University Hospital
Copenhagen, Denmark
St. Vincent's University Hospital
Dublin, Ireland
Azienda USL-IRCCS di Reggio Emilia - Presidio ospedaliero provinciale sede di Reggio Emilia
Reggio Emilia, Italy
Amphia Hospital
Breda, Netherlands
Reinier de Graaf Hospital
Delft, Netherlands
Belfast Trust, City Hospital
Belfast, United Kingdom
Guy's and St Thomas' Hospitals NHS Foundation Trust
London, United Kingdom
King's College Hospital NHS Foundation
London, United Kingdom
Related Publications (7)
Northouse LL, Mood DW, Schafenacker A, Kalemkerian G, Zalupski M, LoRusso P, Hayes DF, Hussain M, Ruckdeschel J, Fendrick AM, Trask PC, Ronis DL, Kershaw T. Randomized clinical trial of a brief and extensive dyadic intervention for advanced cancer patients and their family caregivers. Psychooncology. 2013 Mar;22(3):555-63. doi: 10.1002/pon.3036. Epub 2012 Jan 31.
PMID: 22290823BACKGROUNDNorthouse L, Schafenacker A, Barr KL, Katapodi M, Yoon H, Brittain K, Song L, Ronis DL, An L. A tailored Web-based psychoeducational intervention for cancer patients and their family caregivers. Cancer Nurs. 2014 Sep-Oct;37(5):321-30. doi: 10.1097/NCC.0000000000000159.
PMID: 24945270BACKGROUNDNorthouse L, Kershaw T, Mood D, Schafenacker A. Effects of a family intervention on the quality of life of women with recurrent breast cancer and their family caregivers. Psychooncology. 2005 Jun;14(6):478-91. doi: 10.1002/pon.871.
PMID: 15599947BACKGROUNDLarkin PJ, Dierckx de Casterle B, Schotsmans P. Multilingual translation issues in qualitative research: reflections on a metaphorical process. Qual Health Res. 2007 Apr;17(4):468-76. doi: 10.1177/1049732307299258.
PMID: 17416700BACKGROUNDMay P, Smith S, Jallow M, Kalinjuna T, De Vlemnick A, Matthys O, Van Goethem V, Groenvold M, Guerin S, Turola E, Bakker E, Brazil K, Harding R, Northouse L, Hudson P, Cohen J, Charles N; DIAdIC consortium. Assessing the cost-effectiveness of two psychoeducational interventions for people with cancer and their caregivers: An economic evaluation of the multi-country DIAdIC trial. Contemp Clin Trials. 2026 Jan 21:108240. doi: 10.1016/j.cct.2026.108240. Online ahead of print.
PMID: 41577124DERIVEDDe Vleminck A, Matthys O, Turola E, Dierickx S, Dombrecht L, Van Goethem V, Deliens L, Lapeire L, Hudson P, Eecloo K, Brazil K, Groenvold M, Di Leo S, van der Heide A, Normand C, Harding R, Pilch M, Northouse L; DIAdIC Team; Cohen J. Impact of a nurse-led and a web-based psychoeducational program for advanced cancer patients and their caregivers: Results of a three-arm randomized controlled trial. Int J Nurs Stud. 2025 Nov;171:105192. doi: 10.1016/j.ijnurstu.2025.105192. Epub 2025 Aug 19.
PMID: 40925214DERIVEDMatthys O, De Vleminck A, Dierickx S, Deliens L, Van Goethem V, Lapeire L, Groenvold M, Lund L, Arnfeldt CM, Sengeloev L, Pappot H, Johnsen AT, Guerin S, Larkin PJ, Jordan C, Connolly M, D'Alton P, Costantini M, Di Leo S, Guberti M, Turola E, van der Heide A, Witkamp E, Rietjens J, van der Wel M, Brazil K, Prue G, Reid J, Scott D, Bristowe K, Harding R, Normand C, May P, Cronin C, Northouse L, Hudson P, Cohen J. Effectiveness of a nurse-delivered (FOCUS+) and a web-based (iFOCUS) psychoeducational intervention for people with advanced cancer and their family caregivers (DIAdIC): study protocol for an international randomized controlled trial. BMC Palliat Care. 2021 Dec 28;20(1):193. doi: 10.1186/s12904-021-00895-z.
PMID: 34963453DERIVED
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Joachim Cohen, MSc, PhD
Vrije Universiteit Brussel
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Due to the nature of the intervention neither the patient-caregiver dyads nor the intervention nurses (for the face-to-face FOCUS+ intervention) can be blinded to allocation. Data will be collected via a computer-assisted self-interview with a data collector that is present for assistance and additional explanations. Those conducting the data analyses will be unaware as to what trial arm dyads were randomized to until the end of the last data collection point.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Public Health and Palliative Care
Study Record Dates
First Submitted
October 27, 2020
First Posted
November 12, 2020
Study Start
February 24, 2021
Primary Completion
September 30, 2023
Study Completion
November 30, 2023
Last Updated
June 12, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share